Mesenchymal stem cells: a new strategy for immunosuppression?

This publication has 92 references indexed in Scilit:

• The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse
  BMC Genomics, 2007
• Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/ scid mice
  Proceedings of the National Academy of Sciences, 2006
• Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
  Blood, 2006
• Mesenchymal stem cells enhance xenochimerism in NK-depleted hosts
  Surgery, 2006
• Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
  The Journal of Experimental Medicine, 2006
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
  Cytotherapy, 2006
• Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection
  Expert Opinion on Biological Therapy, 2005
• Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells
  Blood, 2005
• Adult human mesenchymal stem cell as a target for neoplastic transformation
  Oncogene, 2004
• Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
  Annual Review of Immunology, 2001